Literature DB >> 11747217

Metastatic metaplastic carcinoma of the breast (MCB): an uncharacteristic pattern of presentation with clinicopathologic correlation.

J F Catroppo1, J F Lara.   

Abstract

Metaplastic carcinoma of the breast (MCB) is a well recognized but uncommon aberrant manifestation of poorly differentiated invasive carcinoma containing both epithelial (ductal) and mesenchymal elements as well as a transitional form between them. This heterogeneous tumor characteristically contains ductal carcinoma cells mixed with areas of diverse morphologic phenotype displaying spindle, squamous, chondroid, or osseous differentiation. Some studies have suggested that certain types of metaplastic carcinoma have a more favorable prognosis as compared with others. We describe a case involving a 67-yr-old woman who presented with metastatic nodules in the lungs and a vague but recent history of breast cancer. The case highlights a subtype of MCB with a predominant spindle cell component metastatic to the lung. Fine-needle aspiration biopsy (FNAB) smears of the nodules revealed a bland, spindle cell, mesenchymal proliferation with minimal evidence of an epithelial component. A second primary was clinically excluded and a request for review of the original slides identified a metaplastic component to the original tumor with a histologic and immunohistochemical profile identical to the metastatic tumor, confirming origin from the breast. Metaplastic carcinomas of the breast commonly bypass axillary lymph nodes and present as distant metastases. FNAB diagnosis of metaplastic carcinoma of the breast is quite difficult at the primary site and poses a formidable diagnostic challenge at a metastatic site, especially when the dominant pattern is not of the usual type. The literature is reviewed, confirming the rarity of such a presentation and the novelty of this case. Confirmation by FNAB is also quite difficult but may become more commonplace as a trend toward minimal intervention continues to gain popularity. This case emphasizes the importance of recognizing and reporting metaplastic elements in primary breast tumors, as well as the value of direct morphologic comparison of cytologic material from FNABs with archival histologic material. In such situations, the importance of complete and accurate clinicopathologic information is underscored. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11747217     DOI: 10.1002/dc.2056

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Metaplastic Breast Carcinoma with Unusual Presentation: Review of Three Cases.

Authors:  M Asunción Fernández Pérez; Isabel Viqueira Rodriguez; Alberto Tello Royloa; Javier Martínez Guisasola
Journal:  Breast Care (Basel)       Date:  2015-11-18       Impact factor: 2.860

2.  Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report.

Authors:  Claudius Conrad; Diane L Miller; Christina Kaiser; Karl-Walter Jauch; Hanno Nieß; Ralf Huss
Journal:  Breast Care (Basel)       Date:  2011-06-14       Impact factor: 2.860

3.  Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors.

Authors:  Salim Abraham Barquet-Muñoz; Silvia Patricia Villarreal-Colin; Luis Alonso Herrera-Montalvo; Ernesto Soto-Reyes; Carlos Pérez-Plasencia; Jaime Coronel-Martínez; Delia Pérez-Montiel; Rafael Vázquez-Romo; David Cantú de León
Journal:  BMC Cancer       Date:  2015-02-20       Impact factor: 4.430

Review 4.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 5.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

6.  Revisiting Metaplastic Carcinoma of Breast: An Emphasis on the Clinico-pathological and Immunohistochemical Variables Analyzed at a Tertiary Cancer Centre in South India.

Authors:  Geetha V Patil Okaly; C Akshatha; N Sandhya; Akina Prakash; M N Suma; Ashwini Nargund; Shankar Anand; C Ramachandra; Libin Babu Cherian
Journal:  Iran J Pathol       Date:  2021-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.